Healthcare Market due Diligence: An Institutional Checklist for Investment Decisions

Nida Adıyeke

Healthcare market due diligence assesses whether patient demand, reimbursement, competition, access, and regulatory conditions support a proposed healthcare investment. For institutional investors, hospital groups, and strategy teams, the central question is whether the evidence describes the specific opportunity under review—and whether that opportunity remains attractive when its assumptions are tested.

A growing national healthcare market does not automatically justify acquiring a particular hospital. Rising disease prevalence does not necessarily translate into funded treatment demand. Long waiting lists may indicate unmet need, but they do not establish that patients can access, afford, or choose a new provider.

These distinctions become especially important in cross-border investments, where similar headline indicators can conceal different financing systems, referral pathways, workforce constraints, and regulatory requirements.

This institutional checklist provides a practical framework for defining the relevant market, evaluating evidence, testing demand, examining competition, and translating uncertainty into investment decision gates. It is an analytical framework rather than a standardized regulatory checklist; institutions should adapt it to the transaction, service line, and jurisdiction.

What Is Healthcare Market Due Diligence?

Healthcare market due diligence is a structured assessment of the external conditions that could support or undermine a healthcare investment or strategic decision.

It examines the relationship between an investment thesis and the market in which the proposed asset will operate. That includes the patients it intends to serve, the services they need, the mechanisms that fund their care, and the alternatives available to them.

The process should answer five connected questions:

• Is there credible demand for the proposed services?

• Can patients access and pay for those services through the relevant financing arrangements?

• How much demand could the asset realistically capture?

• Can the market and operating environment support the planned expansion?

• Which uncertainties could change the decision, timing, valuation, or transaction terms?

The purpose is to establish which assumptions are supported, which remain uncertain, and which are contradicted by available evidence.

1. Start With the Investment Decision and Transaction Thesis

A useful review begins with a clearly defined decision. Acquiring a hospital, opening an outpatient center, entering a foreign market, and expanding an existing service line require different research questions.

Before collecting market reports, write a short statement explaining why the opportunity is expected to succeed.

For example:

A proposed outpatient imaging center is expected to attract sufficient referred patients within its catchment area because existing providers have limited appointment availability and relevant payers will fund the planned services.

This statement exposes several assumptions. Appointment shortages must be verified. Referral channels must be accessible. Payer coverage must apply to the services and provider. Expected patient volume must be consistent with the center’s capacity and competitive position.

Which Questions Could Change the Decision?

Separate thesis-critical questions from useful background information.

An aging population may provide context. Evidence that the target population cannot obtain coverage for the proposed service could change the investment decision.

For each critical assumption, record:

• The question that needs an answer.

• The evidence required to assess it.

• The person responsible for follow-up.

• The deadline for resolving it.

• The finding that would trigger a change in the investment thesis.

Agree on these questions before commissioning extensive research. Otherwise, diligence can produce a large collection of facts while leaving the central decision unresolved.

Keep Specialist Responsibilities Clear

Market analysis assesses external demand, access, competition, and sector structure. Financial diligence examines earnings quality, costs, and financial exposure. Operational and clinical reviews assess delivery capability and care quality. Legal and regulatory specialists interpret applicable requirements.

These workstreams should exchange findings. They should also retain clear ownership.

For example, a market review may identify a shortage of specialist physicians. The operational team must then assess whether the proposed facility can recruit and retain the workforce needed to deliver its projected services.

2. Define the Market Before Estimating Its Size

Healthcare market estimates are only useful when their boundaries match the investment opportunity.

Define the service line, patient population, geography, care setting, payer segment, and time horizon before comparing figures.

A national estimate for diagnostic services may include laboratory testing, hospital imaging, and outpatient procedures. It cannot automatically support a forecast for a single imaging center in one city.

Define the Service and Patient Population

Specify what the asset will deliver and to whom.

Relevant distinctions may include:

• Inpatient versus outpatient treatment.

• Elective versus urgent care.

• Diagnostic versus therapeutic services.

• Adult versus pediatric patients.

• Publicly funded, privately insured, and self-paying patients.

• Domestic residents versus international patients.

These categories can have different referral routes, payment arrangements, and competitive dynamics. Combining them too early can hide the assumptions that matter most.

Establish a Defensible Catchment Area

Administrative boundaries do not always represent healthcare markets.

Patients may cross municipal boundaries for routine care or travel much farther for specialized treatment. Travel time, transport connections, referral relationships, and the availability of alternatives should inform the catchment definition.

For international patient services, define the source markets separately from the destination market. A hospital’s location describes where care is delivered; it does not establish where its prospective patients originate.

Distinguish Total Demand From Addressable Demand

Keep three concepts separate:

Total potential need describes the population that may clinically require a service.

Addressable demand describes the portion of that need that could reach and obtain the proposed service under relevant access and payment conditions.

Realistically capturable volume describes the patients the asset could attract within its competitive and operational constraints.

An investment forecast should explain how it moves between these concepts. A large estimate of clinical need should not become a patient-volume forecast without supporting evidence.

3. Test Whether Patient Need Can Become Service Utilization

One of the most consequential questions in healthcare market due diligence is whether identified need can translate into actual care.

Disease prevalence, population growth, and demographic change can inform the assessment. They do not independently establish utilization.

The analysis must examine the pathway connecting a patient’s need to an appointment, diagnosis, procedure, or completed treatment.

Assess the Demand Pathway

Review the relevant stages:

• Recognition of a health need.

• Access to assessment or diagnosis.

• Referral to an appropriate provider.

• Eligibility for coverage or ability to pay.

• Availability of an appointment or treatment slot.

• Completion of the required care.

A constraint at any stage may reduce realized volume.

For example, a region may have a substantial population requiring specialist care while referral restrictions or unaffordable patient payments limit the number who can use a proposed private facility.

WHO identifies financing as a core health-system function and notes that treatment costs prevent many people from accessing services. This supports examining affordability and funding alongside clinical need.

Examine Referral Dependence

When growth depends on referrals, identify the sources and test the assumptions behind them.

Questions should include:

• Are referrals concentrated among a small number of physicians or institutions?

• Do prospective referral partners already have established provider relationships?

• What evidence supports their willingness to refer?

• Could payer networks or referral rules restrict patient choice?

• Would the projected volume depend on one agreement or individual?

Distinguish informal expressions of interest from established referral activity. Interviews can explain how a market works, but a positive conversation should not be counted as committed patient volume.

Interpret Waiting Lists Carefully

Waiting lists can provide evidence of access constraints. Their commercial implications require further investigation.

Determine which services are affected, how waiting times are measured, and whether patients have an accessible alternative. Assess whether funding arrangements allow treatment to move to another provider.

A waiting list may support the case for additional capacity. It does not establish that a particular asset can capture the waiting patients.

4. Evaluate Reimbursement, Payer Mix, and Affordability

A healthcare market may demonstrate substantial need while offering limited funded demand for the proposed business model.

Market diligence should therefore establish who pays, what is covered, how providers receive payment, and which conditions affect access.

WHO’s work on strategic purchasing highlights the relationship between benefit design, provider payment, information, and governance. For investors, these are relevant areas to investigate when assessing whether demand can support a proposed service model.

Which Payment Assumptions Need Verification?

Examine:

• Coverage for the specific service and patient group.

• Provider eligibility and network participation.

• Referral and prior-authorization requirements.

• Patient cost-sharing or self-payment.

• Applicable tariffs, negotiated rates, and payment units.

• Material policy changes or unresolved coverage questions.

Use current, jurisdiction-specific sources. Ask the relevant specialist to verify contractual or regulatory interpretations.

Do not assume that a reimbursement arrangement in one country applies to another, or that national coverage necessarily extends to the proposed provider.

Test Payer Concentration

An opportunity may depend heavily on one insurer, public purchaser, employer group, or intermediary.

Assess how that concentration affects market access. If a major payer changes its network, covered benefits, or purchasing approach, the asset’s addressable demand may change.

The financial team should assess the implications for revenue and cash flow. The market team should establish how dependent projected utilization is on those arrangements.

5. Map the Competitive Landscape Beyond Direct Rivals

A useful competitor review includes every relevant alternative that could influence patient choice, referrals, or available volume.

Depending on the service, these alternatives may include hospitals, outpatient centers, public facilities, specialist practices, home-based services, or providers in another region.

The question is how patients and payers choose between available care pathways.

Compare What Can Be Verified

Assess competitors using sourced information about:

• Location and accessibility.

• Relevant service mix.

• Payer participation.

• Appointment availability.

• Capacity and reported activity.

• Referral relationships.

• Pricing where comparable.

• Patient experience and clinical-quality indicators where reliably available.

Keep licensed capacity, installed capacity, staffed capacity, and actual utilization separate. A facility with equipment or beds available on paper may not have the workforce or demand to use them fully.

Likewise, a provider’s claim to be a market leader should not be treated as independently verified market share.

Consider Competitive Response

Current conditions may change after entry or expansion.

An incumbent might extend operating hours, add capacity, negotiate new payer arrangements, or strengthen referral relationships. These possibilities should be assessed according to available evidence rather than assumed as certain outcomes.

Ask whether the investment depends on competitors maintaining their present behavior. If so, include a plausible competitive response in the downside analysis.

6. Test Capacity and Workforce Constraints

A market opportunity must be connected to a feasible delivery model.

Additional patient demand may require specialist staff, diagnostic support, operating-theater access, nursing coverage, rehabilitation, or follow-up capacity. One constrained component can limit the entire service pathway.

Identify the Binding Constraint

Establish which resource most directly limits achievable volume.

For an imaging center, the constraint might be equipment availability, reporting capacity, or referral access. For a surgical service, it might be specialist recruitment, theater time, or postoperative beds.

Market analysis should identify external constraints, including workforce availability and competing demand for scarce skills. Operational diligence should test the asset’s ability to manage them.

Challenge the Expansion Timeline

Separate the date capacity is planned from the date it can realistically become productive.

Recruitment, commissioning, payer participation, and referral development may progress at different speeds. A forecast should explain the assumptions behind its ramp-up period.

Avoid projecting mature utilization from the opening date unless the evidence supports that expectation.

7. Validate Evidence Before Relying on Forecasts

Healthcare market due diligence requires a clear record of where material inputs come from and what they measure.

Two reports may discuss the same sector while covering different populations, services, periods, or geographic boundaries. Their estimates should not be treated as interchangeable.

OECD’s guidance for international health comparisons directs readers to indicator definitions, sources, methods, and comparability limitations. The same discipline is useful when evaluating market evidence for an investment.

Maintain an Evidence Register

For each material input, record:

• Source and publication date.

• Reporting period.

• Geographic coverage.

• Population and service definition.

• Methodology.

• Relevant exclusions and limitations.

• Whether the input is observed, modeled, self-reported, or assumed.

Evaluate evidence according to its fitness for the question. Official data may be robust but too aggregated for a local decision. Provider disclosures may be specific but require corroboration. Expert interviews may reveal referral behavior while offering limited support for a numerical market estimate.

Avoid False Triangulation

Several reports repeating the same underlying estimate do not provide independent confirmation.

Trace important figures to their original source where possible. Check whether apparent agreement reflects independent measurement or repeated citation.

When estimates conflict, investigate definitions, periods, and methods before choosing a preferred figure. Explain why the selected input best matches the market under review.

Record What Remains Unknown

An unavailable figure should remain an evidence gap until it is resolved or explicitly treated as an assumption.

State how the gap affects the conclusion and what could resolve it. This is more useful than presenting a precise forecast whose most influential inputs cannot be verified.

8. Examine Regulatory and Cross-Border Exposure

Regulatory conditions can influence market entry, service availability, patient access, and the feasibility of expansion.

Identify the requirements and policy dependencies relevant to the transaction. Refer their interpretation to qualified specialists in the applicable jurisdiction.

Potential areas for review include facility licensing, professional authorization, ownership restrictions, service approvals, payer eligibility, advertising rules, and health-data requirements.

What Changes in Cross-Border Healthcare Investments?

International comparisons need particular care because similarly named services or indicators may operate within different systems.

Assess differences in:

• Coverage and referral arrangements.

• Provider authorization and accreditation.

• Service definitions and reporting practices.

• Workforce availability.

• Patient payment and currency exposure.

• Travel access and continuity of care.

For medical tourism investments, separate interest in treatment from completed patient journeys. Assess how diagnosis, travel, payment, treatment, and follow-up connect.

A destination’s general popularity does not independently validate demand for a particular procedure or provider.

9. Stress-Test the Assumptions That Drive the Thesis

A single forecast can conceal how sensitive the opportunity is to uncertain inputs.

Identify the assumptions with the greatest effect on projected volume and market access. Then test how the conclusion changes when those assumptions vary.

Relevant variables may include referral conversion, utilization, payer participation, affordability, recruitment timing, competitor expansion, and international patient flows.

Build Coherent Scenarios

A practical assessment can distinguish:

Base case: The outcome supported by the most relevant evidence and explicit operating assumptions.

Downside case: A plausible combination of weaker demand, slower access development, or tighter delivery constraints.

Upside case: An outcome requiring favorable assumptions that have a stated evidentiary basis.

Explain how each scenario is constructed. A downside case that simply reduces every forecast by an arbitrary percentage may miss the mechanism most likely to undermine the investment.

Avoid Unsupported Precision

A scenario illustrates conditional outcomes; it is not a guarantee.

If probabilistic modeling is used, explain the basis of input distributions and relationships between variables. More sophisticated modeling does not compensate for poorly defined markets or unsupported assumptions.

Decision-makers should be able to see which inputs drive the result and how reliable those inputs are.

10. Convert Findings Into Decision Gates

Market research becomes useful when it changes or confirms an action.

For each material finding, identify the assumption it tests, the strength of the evidence, and the consequence for the decision.

Distinguish an information gap from a structural constraint. Missing referral evidence may be resolved through targeted research. A persistent restriction on market access may require a different operating model or a revised thesis.

Define the Available Actions

An institution can use four practical responses:

• Escalate: Refer a material finding to the appropriate decision-maker or specialist.

• Mitigate: Assess an action that could reduce the exposure.

• Condition: Require defined evidence or resolution before commitment.

• Reassess: Revise the thesis, timing, terms, or decision.

Set thresholds appropriate to the transaction. A vague condition such as “confirm market demand” leaves too much room for interpretation.

A stronger condition identifies the relevant patient segment, required evidence, responsible reviewer, and deadline.

Preserve an Audit Trail

Record why the team reached its conclusion and what evidence would change it.

This allows decision-makers to distinguish a verified finding from an accepted uncertainty. It also supports later review if the market evolves or the transaction assumptions need updating.

An Institutional Healthcare Market Due Diligence Checklist

Before presenting a recommendation, confirm that the review addresses the following questions:

1. Decision: Is the proposed investment or strategic action clearly defined?

2. Thesis: Are the assumptions required for success explicit?

3. Market boundaries: Do the service, population, geography, payer segment, and period match the asset?

4. Demand: Is clinical need distinguished from accessible, funded utilization?

5. Referrals: Are material referral assumptions supported by evidence?

6. Payment: Are coverage, provider participation, and affordability assessed?

7. Competition: Are direct providers, substitutes, and plausible responses considered?

8. Capacity: Are workforce and delivery constraints linked to achievable volume?

9. Evidence: Are sources, definitions, limitations, and assumptions traceable?

10. Regulation: Are jurisdiction-specific dependencies identified and assigned for specialist review?

11. Scenarios: Are the assumptions most likely to change the conclusion tested?

12. Decision gates: Are unresolved issues connected to owners, deadlines, and approval conditions?

The checklist should remain proportionate to the transaction. Its value comes from resolving consequential questions, rather than treating every item as equally material.

What Should a Decision-Ready Diligence Report Contain?

The executive synthesis should explain what the evidence means for the proposed decision.

It should present the defined market, core thesis assumptions, principal findings, confidence levels, and unresolved conditions. Supporting material should preserve source details and the reasoning behind estimates.

A decision-ready report should make clear:

• Which assumptions the evidence supports.

• Which findings challenge the thesis.

• Which uncertainties remain material.

• What further work is required.

• Whether the findings affect approval, timing, scope, or terms.

Keep the most consequential issues visible in the main report. An extensive appendix cannot compensate for an executive summary that obscures an unresolved dependency.

When Is Additional Market Intelligence Useful?

Focused research may be appropriate when evidence is fragmented, a service line is specialized, or the institution lacks familiarity with a regional healthcare system.

Define the gap before seeking further analysis. A request to investigate payer access for a specific service in a defined geography is more actionable than a general request for another country report.

Additional intelligence should strengthen the institution’s own assessment and connect with financial, operational, clinical, and legal workstreams.

For broader perspectives on healthcare investment and international patient mobility, explore News NestHeal Insights.

Stronger Decisions Begin With Explicit Assumptions

Healthcare market due diligence cannot remove uncertainty from an investment. It can make that uncertainty visible, test its significance, and establish what must be resolved before commitment.

A credible assessment connects patient need to access, payment, competition, and delivery capacity. It checks whether sources describe the same market and makes clear where forecasts depend on assumptions.

The resulting recommendation should give decision-makers a defensible basis for proceeding, changing the proposal, requesting further evidence, or declining the opportunity.

Policies

Editorial Policy

Fact-Checking Policy

Corrections Policy

Ethics Policy